Fondazione IRCCS Istituto Nazionale dei Tumori, Milano clinical trials

Listed in the registry as: University, hospital or other organization.

The registry lists 172 studies whose lead sponsor is Fondazione IRCCS Istituto Nazionale dei Tumori, Milano. 50 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 21, 2026.

Keep track of what changes. Save the Fondazione IRCCS Istituto Nazionale dei Tumori, Milano studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Status

Completed: 70
Recruiting: 39
Status unknown: 37
Not yet recruiting: 9
Active, not recruiting: 8
Terminated: 5

Phase

Phase 2: 68
Phase 3: 8
Phase 1: 3
Phase 4: 3
Early Phase 1: 1

Where

Italy: 161
Germany: 6
Spain: 5
United Kingdom: 5
Poland: 5
Austria: 4

Focus areas

Conditions Fondazione IRCCS Istituto Nazionale dei Tumori, Milano leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Carcinoma25 Breast Neoplasms19 Colorectal Neoplasms11 Carcinoma, Renal Cell10 Urinary Bladder Neoplasms10

Studies

Recruiting first, then most recently updated. Showing 50 of 172. Browse all 172 →